EMV
EMVISION FPO [EMV]
Healthcare · ASX Small Cap
$1.8000 -2.2%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 4 consecutive scansFirst seen: 2026-03-03
Get alerts when EMV triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Trading above both moving averages — the trend is your friend here
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (11 quarters)
- Strong revenue growth (+188%)
- EPS estimates revised downward (-10pts)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +188% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.69%/day)
- RBA hiking (-3pts)
- Trial readout: (est. 2026-11-01)
Risk Signals
- Deeply negative margins (-100%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Expected next for EMV
Window: 24 Oct to 7 Nov
The last 8 moved EMV -0.7% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE emu Regional Benefits Study Advancing
NONE FY26 Results Presentation
NONE Appendix 4G & Corporate Governance Statement
HIGH emu Pivotal Trial Recruitment Surpasses 200 Patients
LOW Appendix 4E & Annual Report to 30 June 2026
Recent ASX Announcements
| 2026-09-02 | emu Regional Benefits Study Advancing PRICE SENSITIVE |
| 2026-08-30 | emu Pivotal Trial Recruitment Surpasses 200 Patients PRICE SENSITIVE |
| 2026-08-23 | FY26 Results Presentation |
| 2026-08-23 | Appendix 4G & Corporate Governance Statement |
| 2026-08-23 | Appendix 4E & Annual Report to 30 June 2026 PRICE SENSITIVE |
Key Metrics
$167.8M
Market Cap
38K
Avg Volume
1.0x
Vol Ratio
$1.47 — $2.43
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-66.4%
ROE
-99.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 66% |
| L | Leader vs Laggard | pass | RS: 11 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track EMV and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required